SLC38A11

gene
On this page

Also known as FLJ39822AVT2

Summary

SLC38A11 (solute carrier family 38 member 11, HGNC:26836) is a protein-coding gene on chromosome 2q24.3, encoding Putative sodium-coupled neutral amino acid transporter 11 (Q08AI6). Putative sodium-dependent amino acid/proton antiporter.

Predicted to enable L-amino acid transmembrane transporter activity. Predicted to be involved in amino acid transmembrane transport. Predicted to be active in membrane.

Source: NCBI Gene 151258 — RefSeq curated summary.

At a glance

  • GWAS associations: 38
  • Clinical variants (ClinVar): 77 total — 1 pathogenic
  • MANE Select transcript: NM_001351537

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:26836
Approved symbolSLC38A11
Namesolute carrier family 38 member 11
Location2q24.3
Locus typegene with protein product
StatusApproved
AliasesFLJ39822, AVT2
Ensembl geneENSG00000169507
Ensembl biotypeprotein_coding
OMIM616526
Entrez151258

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 6 protein_coding, 4 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000303735, ENST00000409058, ENST00000409149, ENST00000409662, ENST00000424914, ENST00000465898, ENST00000470576, ENST00000483641, ENST00000492134, ENST00000493887, ENST00000685975

RefSeq mRNA: 6 — MANE Select: NM_001351537 NM_001199148, NM_001351537, NM_001351538, NM_001351539, NM_001351540, NM_173512

CCDS: CCDS2224, CCDS56142, CCDS92885

Canonical transcript exons

ENST00000685975 — 12 exons

ExonStartEnd
ENSE00001130083164939450164939556
ENSE00001130511164911636164911748
ENSE00001582244164944569164944634
ENSE00003478006164954631164954745
ENSE00003517409164937350164937429
ENSE00003531046164945593164945727
ENSE00003567881164915112164915273
ENSE00003628013164915903164915973
ENSE00003672515164908640164908771
ENSE00003928844164955209164955525
ENSE00003932117164952707164952781
ENSE00003934453164894354164898730

Expression profiles

Bgee: expression breadth ubiquitous, 185 present calls, max score 94.98.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.7837 / max 90.9503, expressed in 177 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
316450.2395100
316440.221399
316430.126341
316420.079838
316470.059223
316460.057729

Top tissues by expression

250 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
corpus epididymisUBERON:000435994.98gold quality
gall bladderUBERON:000211091.68gold quality
pancreatic ductal cellCL:000207991.22gold quality
metanephros cortexUBERON:001053389.60gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047387.82gold quality
epithelial cell of pancreasCL:000008385.95silver quality
primary visual cortexUBERON:000243685.80gold quality
spleenUBERON:000210681.86gold quality
right frontal lobeUBERON:000281081.20gold quality
caput epididymisUBERON:000435881.14gold quality
body of stomachUBERON:000116180.88gold quality
endothelial cellCL:000011579.83silver quality
middle temporal gyrusUBERON:000277179.70gold quality
occipital lobeUBERON:000202179.56gold quality
stomachUBERON:000094579.17gold quality
putamenUBERON:000187477.77gold quality
prostate glandUBERON:000236777.71gold quality
anterior cingulate cortexUBERON:000983576.97gold quality
Brodmann (1909) area 9UBERON:001354076.96gold quality
cauda epididymisUBERON:000436076.90gold quality
seminal vesicleUBERON:000099876.74gold quality
pigmented layer of retinaUBERON:000178276.47gold quality
retinaUBERON:000096676.46gold quality
adenohypophysisUBERON:000219676.04gold quality
caudate nucleusUBERON:000187375.88gold quality
body of pancreasUBERON:000115075.75gold quality
dorsolateral prefrontal cortexUBERON:000983475.74gold quality
amygdalaUBERON:000187675.31gold quality
rectumUBERON:000105274.98gold quality
Brodmann (1909) area 23UBERON:001355474.98gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-MTAB-8495yes531.86
E-HCAD-35yes8.29
E-ANND-3yes6.93
E-GEOD-125970yes5.13

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): CLDN19, CLDN3

miRNA regulators (miRDB)

26 targeting SLC38A11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4262100.0073.263931
HSA-MIR-5692A100.0074.406850
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-480399.9871.993117
HSA-MIR-477599.9875.006394
HSA-MIR-32-5P99.9875.211964
HSA-MIR-92A-3P99.9875.211960
HSA-MIR-92B-3P99.9875.251955
HSA-MIR-25-3P99.9874.601817
HSA-MIR-363-3P99.9874.721821
HSA-MIR-367-3P99.9874.831819
HSA-MIR-570-3P99.9672.414910
HSA-MIR-590-3P99.9674.346478
HSA-MIR-145-5P99.9271.131836
HSA-MIR-5195-3P99.9270.921877
HSA-MIR-627-3P99.9071.423316
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-608399.4768.732393
HSA-MIR-448099.4266.02735
HSA-MIR-410-3P99.2769.982457
HSA-MIR-6739-3P99.2268.841843
HSA-MIR-375-3P97.9165.12483
HSA-MIR-3691-3P97.9065.97791

Cross-species orthologs

10 orthologs

OrganismSymbolGene ID
danio_rerioslc38a11ENSDARG00000040257
mus_musculusSlc38a11ENSMUSG00000061171
rattus_norvegicusSlc38a11ENSRNOG00000004966
drosophila_melanogasterCG13743FBGN0033368
caenorhabditis_elegansslc-36.4WBGENE00010421
caenorhabditis_elegansY18D10A.23WBGENE00012487
caenorhabditis_elegansWBGENE00012629
caenorhabditis_elegansWBGENE00012804
caenorhabditis_elegansWBGENE00019837
caenorhabditis_elegansWBGENE00020837

Paralogs (15): SLC38A5 (ENSG00000017483), SLC32A1 (ENSG00000101438), SLC38A7 (ENSG00000103042), SLC38A1 (ENSG00000111371), SLC36A1 (ENSG00000123643), SLC38A2 (ENSG00000134294), SLC38A4 (ENSG00000139209), SLC38A6 (ENSG00000139974), SLC38A10 (ENSG00000157637), SLC38A8 (ENSG00000166558), SLC38A9 (ENSG00000177058), SLC36A4 (ENSG00000180773), SLC36A3 (ENSG00000186334), SLC36A2 (ENSG00000186335), SLC38A3 (ENSG00000188338)

Protein

Protein identifiers

Putative sodium-coupled neutral amino acid transporter 11Q08AI6 (reviewed: Q08AI6)

Alternative names: Solute carrier family 38 member 11

All UniProt accessions (4): A0A8I5QKK7, B8ZZ86, Q08AI6, H7C1P1

UniProt curated annotations — full annotation on UniProt →

Function. Putative sodium-dependent amino acid/proton antiporter.

Subcellular location. Membrane.

Similarity. Belongs to the amino acid/polyamine transporter 2 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q08AI6-11yes
Q08AI6-22

RefSeq proteins (6): NP_001186077, NP_001338466, NP_001338467, NP_001338468, NP_001338469, NP_775783 (=MANE)

Domains & families (InterPro)

IDNameType
IPR013057AA_transpt_TMDomain

Pfam: PF01490

UniProt features (16 total): transmembrane region 10, glycosylation site 2, chain 1, topological domain 1, splice variant 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q08AI6-F188.500.74

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 44, 275

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 71 (showing top): GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_ORGANIC_ACID_TRANSPORT, chr2q24, GOBP_AMINO_ACID_TRANSPORT, GOBP_ORGANIC_ANION_TRANSPORT, HAND1E47_01, LINDVALL_IMMORTALIZED_BY_TERT_UP, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_TRANSPORTER_ACTIVITY, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, RATTENBACHER_BOUND_BY_CELF1

GO Biological Process (5): amino acid transmembrane transport (GO:0003333), sodium ion transport (GO:0006814), monoatomic ion transport (GO:0006811), amino acid transport (GO:0006865), L-alpha-amino acid transmembrane transport (GO:1902475)

GO Molecular Function (2): L-amino acid transmembrane transporter activity (GO:0015179), protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport2
amino acid transport1
transmembrane transport1
metal ion transport1
amino acid transmembrane transport1
L-amino acid transport1
carboxylic acid transmembrane transport1
amino acid transmembrane transporter activity1
carboxylic acid transmembrane transporter activity1
L-alpha-amino acid transmembrane transport1
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

543 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC38A11REELD1A0A1B0GV85595
SLC38A11SLC38A9Q8NBW4560
SLC38A11C16orf96A6NNT2551
SLC38A11ZNF142P52746460
SLC38A11SLC7A4O43246452
SLC38A11SLC43A2Q8N370433
SLC38A11COBLL1Q53SF7419
SLC38A11SLC6A15Q9H2J7381
SLC38A11GLB1LQ6UWU2380
SLC38A11CSRNP3Q8WYN3374
SLC38A11KRTAP19-1Q8IUB9366
SLC38A11GJD4Q96KN9364
SLC38A11SLC3A1Q07837360
SLC38A11SLC38A10Q9HBR0355
SLC38A11SLC7A8Q9UHI5351

IntAct

4 interactions, top by confidence:

ABTypeScore
TUSC5SLC38A11psi-mi:“MI:0915”(physical association)0.560
TUSC5SLC38A11psi-mi:“MI:0915”(physical association)0.000

BioGRID (2): TUSC5 (Two-hybrid), SLC38A11 (Affinity Capture-MS)

ESM2 similar proteins: A1YG32, A2VCW5, A2VE31, D3Z813, F4KBM7, G3UVW3, O80668, P38176, P39981, P40074, P40501, P47082, Q08AI6, Q0WQJ3, Q17598, Q19425, Q28HE5, Q28I47, Q3U1J0, Q3USY0, Q503G8, Q54S12, Q5E9S9, Q5EA97, Q5F468, Q5R443, Q5RE87, Q5SPB1, Q5XH90, Q610N4, Q6DEL1, Q6DFE7, Q6WWW3, Q8CFE6, Q8HXI3, Q8IZM9, Q8K2P7, Q8R1S9, Q8WUX1, Q969I6

Diamond homologs: A8KBL5, D3Z813, P39981, Q08AI6, Q3USY0, Q5EA97, Q5RE87, Q8HXI3, Q969I6, P38176, P40074, P40501

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

77 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance64
Likely benign2
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1526927GRCh37/hg19 2q24.2-24.3(chr2:163168812-167567296)Pathogenic

SpliceAI

2222 predictions. Top by Δscore:

VariantEffectΔscore
2:164908632:GTAC:Gdonor_loss1.0000
2:164908633:TAC:Tdonor_loss1.0000
2:164908634:A:ACdonor_gain1.0000
2:164908634:AC:Adonor_loss1.0000
2:164908635:C:CCdonor_gain1.0000
2:164908635:CTCA:Cdonor_gain1.0000
2:164908636:TCA:Tdonor_loss1.0000
2:164908637:C:CCdonor_loss1.0000
2:164908638:A:ACdonor_gain1.0000
2:164908638:A:Cdonor_loss1.0000
2:164908639:C:CCdonor_gain1.0000
2:164908639:C:CGdonor_loss1.0000
2:164908639:CA:Cdonor_gain1.0000
2:164908639:CATTG:Cdonor_gain1.0000
2:164915213:G:Cdonor_gain1.0000
2:164915894:AATAC:Adonor_loss1.0000
2:164915895:ATACT:Adonor_loss1.0000
2:164915896:TACTC:Tdonor_loss1.0000
2:164915897:AC:Adonor_loss1.0000
2:164915898:C:CGdonor_loss1.0000
2:164915899:T:TCdonor_loss1.0000
2:164915900:CA:Cdonor_loss1.0000
2:164915901:A:Cdonor_loss1.0000
2:164915974:C:CCacceptor_gain1.0000
2:164937344:A:Cdonor_gain1.0000
2:164937344:ACTT:Adonor_loss1.0000
2:164937345:CTT:Cdonor_loss1.0000
2:164937346:TTA:Tdonor_loss1.0000
2:164937348:A:ACdonor_gain1.0000
2:164937348:ACATG:Adonor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000031962 (2:164905055 G>T), RS1000090344 (2:164956934 A>G), RS1000120145 (2:164956740 TGAC>T), RS1000173879 (2:164912361 T>C), RS1000321133 (2:164949556 T>A,C), RS1000325395 (2:164950606 G>T), RS1000373365 (2:164949774 G>C), RS1000380627 (2:164937401 G>A), RS1000438262 (2:164910874 C>T), RS1000494287 (2:164912330 T>A), RS1000568363 (2:164925578 A>G), RS1000599306 (2:164925877 C>G), RS1000751577 (2:164905370 G>A), RS1000758625 (2:164911975 T>C), RS1000812456 (2:164942384 A>G)

Disease associations

OMIM: gene MIM:616526 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

38 associations (top):

StudyTraitp-value
GCST002579_8Heschl’s gyrus morphology2.000000e-06
GCST005950_14Body mass index x sex x age interaction (4df test)4.000000e-07
GCST005951_55Body mass index3.000000e-06
GCST005952_7Body mass index (age>50)4.000000e-09
GCST005956_34Waist-to-hip ratio adjusted for BMI2.000000e-13
GCST005957_2Waist-to-hip ratio adjusted for BMI (age <50)1.000000e-16
GCST005958_3Waist-to-hip ratio adjusted for BMI (age >50)1.000000e-16
GCST005962_14Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)1.000000e-29
GCST011687_2Systolic blood pressure6.000000e-07
GCST90020024_1152A body shape index2.000000e-12
GCST90020024_1153A body shape index2.000000e-11
GCST90020024_1154A body shape index7.000000e-09
GCST90020025_1719Waist-to-hip ratio adjusted for BMI4.000000e-14
GCST90020025_1724Waist-to-hip ratio adjusted for BMI1.000000e-21
GCST90020025_1725Waist-to-hip ratio adjusted for BMI2.000000e-19
GCST90020025_1726Waist-to-hip ratio adjusted for BMI4.000000e-15
GCST90020025_1727Waist-to-hip ratio adjusted for BMI5.000000e-08
GCST90020025_1728Waist-to-hip ratio adjusted for BMI7.000000e-10
GCST90020025_1729Waist-to-hip ratio adjusted for BMI1.000000e-11
GCST90020025_1730Waist-to-hip ratio adjusted for BMI1.000000e-09
GCST90020025_1731Waist-to-hip ratio adjusted for BMI1.000000e-10
GCST90020026_366Hip index3.000000e-10
GCST90020026_367Hip index5.000000e-09
GCST90020026_368Hip index1.000000e-09
GCST90020027_566Waist-hip index2.000000e-13
GCST90020027_571Waist-hip index1.000000e-21
GCST90020027_572Waist-hip index7.000000e-20
GCST90020027_573Waist-hip index7.000000e-15
GCST90020027_574Waist-hip index3.000000e-08
GCST90020027_575Waist-hip index4.000000e-08

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0008007age at assessment
EFO:0008343sex interaction measurement
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0006335systolic blood pressure
EFO:0007789BMI-adjusted waist circumference
EFO:0008039BMI-adjusted hip circumference

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — Orphan SLC38 transporters

CTD chemical–gene interactions

18 total (human), top 18 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, decreases methylation4
Cyclosporinedecreases expression3
Estradioldecreases expression, affects expression2
Tetrachlorodibenzodioxindecreases expression2
Aflatoxin B1affects expression, decreases expression2
mivebresibdecreases expression1
fluorene-9-bisphenolincreases expression1
methyleugenoldecreases expression1
tris(2-butoxyethyl) phosphateaffects expression1
2,6-dichloro-(1,4)benzoquinoneincreases expression1
Vorinostatdecreases expression1
Acetaminophendecreases expression1
Amiodaroneincreases expression1
Azathioprinedecreases expression1
Quercetindecreases expression1
Silicon Dioxidedecreases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D4TEHuH7-SLC38A11-KO-c4Cancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.